Funded Tech Companies
Dewpoint Therapeutics
Wondering who invested in Dewpoint Therapeutics? Leaps by Bayer, Mirae Asset Venture Investment and Polaris Partners put venture money into this biopharmaceutical company.
Company Overview
Company Name
Dewpoint Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
6 Tide St. 300
Boston, MA 02210
USA
Boston, MA 02210
USA
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Dewpoint is translating new insights into biomolecular condensates and cellular function to uncover treatments for the toughest diseases.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
2/12/2022
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Amir Nashat
Chief Operating Officer
Bruce Beutel
Chief Scientific Officer
Mark Murcko
Founder
Anthony Hyman
Founder
Richard Young
Vice President
William Chen
Vice President
Peter Dandliker
Vice President
Stephen Hale
Vice President
Alexander Szewczak
Vice President
Rebecca Zacks
VP - Bus. Development
Scott Peterson
VP - Human Resources
Holly Abernethy
VP - R & D
Ann Kwong
Company Investors
- Leaps by Bayer
- Mirae Asset Venture Investment
- Polaris Partners (Amir Nashat)
- 3E Bioventures
- NS Investment
- General Catalyst Partners
- SoftBank Vision Fund (Vikas Parekh)
- EcoR1 Capital Management
- Mubadala
- Arch Venture Partners
- Samsara BioCapital
- Maverick Ventures Israel
- Innovation Endeavors
- Bellco Capital
- Alexandria Venture Investments
- 6 Dimensions Capital
Browse more funded tech companies:
Share this article
About Our VC Transaction Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs